Genprex is committed to pay Manhattan Street Capital these fees; Cash of $15k with the option to pay $30k in equity instead of cash. Warrants with face value of $30k priced at the average of the recent ...
RodTurners Blog Genprex is raising capital through their IPO ... Genprex has developed Oncoprex, a unique medicine that is delivered to lung ... system to attack the tumors. Genprex is raising $6.5 mill at a pre-money ...
RodTurner's blog Prospectus. Genprex is raising capital through ... Varner, CEO of Genprex, said, "Had I known the benefits of using Reg A ... treatment to the tumors effectively is a major challenge. Genprex hat ...
RodTurner's blog Prospectus. Genprex has completed its S-1 IPO ... Capital has rights to warrants in Genprex, so we have a conflict ... to the tumors effectively is a major challenge. Genprex has developed a unique ...
RodTurners Blog Genprex (S-1 IPO) expects to list on the NASDAQ on Friday March 16 th- two days left. Their Oncoprex medicine ... cell death. Genprex is raising $6.5 mill at a pre-money valuation ...
Abgeschlossene S-1 IPO NASDAQ: GNPX Lungenkrebs Klinische Stage Gentherapie
Versicherer; Anwalt für Finanz-Underwriter bei Network1; Philip Magri Magri Law LLC, Ft. Lauderdale, FL Genprex Rat; Christopher J. Ozburn, Streusand Landon & Ozburn, LLP. Transferagent Austin TX; V Lager ...
Privates Angebot für vermögende Anleger
